{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:13:29Z","timestamp":1790957609323,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.arteri.2016.07.005","type":"journal-article","created":{"date-parts":[[2016,11,15]],"date-time":"2016-11-15T23:37:09Z","timestamp":1479253029000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Paraoxonase 1 (Q192R) gene polymorphism, coronary heart disease and the risk of a new acute coronary event"],"prefix":"10.1016","volume":"29","author":[{"given":"Efr\u00e9n","family":"Mart\u00ednez-Quintana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fayna","family":"Rodr\u00edguez-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Mar\u00eda","family":"Medina-Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paloma","family":"Garay-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Tugores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arteri.2016.07.005_bib0140","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.2217\/pgs.13.147","article-title":"Pharmacogenetics of paraoxonase activity: elucidating the role of high-density lipoprotein in disease","volume":"14","author":"Kim","year":"2013","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.arteri.2016.07.005_bib0145","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/MOL.0b013e32835ffcfd","article-title":"Paraoxonase 1 activities, regulation, and interactions with atherosclerotic lesion","volume":"24","author":"Aviram","year":"2013","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.arteri.2016.07.005_bib0150","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.atherosclerosis.2013.03.005","article-title":"Paraoxonase 1 (PON1) reduces macrophage inflammatory responses","volume":"228","author":"Aharoni","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.arteri.2016.07.005_bib0155","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/28406","article-title":"Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis","volume":"394","author":"Shih","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.arteri.2016.07.005_bib0160","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/01.CIR.0000023623.87083.4F","article-title":"Decreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice","volume":"106","author":"Tward","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.arteri.2016.07.005_bib0165","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0894-7317(89)80014-8","article-title":"Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards Subcommittee on Quantitation of Two-Dimensional Echocardiography","volume":"2","author":"Schiller","year":"1989","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.arteri.2016.07.005_bib0170","unstructured":"National Center for Biotechnology Information. Information for SNP ID rs662, http:\/\/www.ncbi.nlm.nih.gov\/projects\/SNP\/snp_ref.cgi?rs=662 (accessed on November 2011)."},{"key":"10.1016\/j.arteri.2016.07.005_bib0175","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1161\/01.CIR.0000070954.00271.13","article-title":"Low paraoxonase activity predicts coronary events in the Caerphilly prospective study","volume":"107","author":"Mackness","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.arteri.2016.07.005_bib0180","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0167-5273(02)00595-8","article-title":"PON1 activities and oxidative markers of LDL in patients with angiographically proven coronary artery disease","volume":"91","author":"Azarsiz","year":"2003","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.arteri.2016.07.005_bib0185","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11010-013-1665-z","article-title":"The Q192R polymorphism of the paraoxonase 1 gene is a risk factor for coronary artery disease in Saudi subjects","volume":"380","author":"Hassan","year":"2013","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.arteri.2016.07.005_bib0190","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0021-9150(99)00340-8","article-title":"Evidence for association between paraoxonase gene polymorphisms and atherosclerotic diseases","volume":"149","author":"Imai","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.arteri.2016.07.005_bib0195","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1172\/JCI118869","article-title":"The Gln-Arg 191 polymorphism of human paraoxonase gene (HUMPONA) is not associated with the risk of coronary artery disease in Finns","volume":"98","author":"Antikainen","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.arteri.2016.07.005_bib0200","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0021-9150(96)05917-5","article-title":"The Gln\/Arg polymorphism of human paraoxonase (PON 192) is not related to myocardial infarction in the ECTIM study","volume":"126","author":"Herrmann","year":"1996","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.arteri.2016.07.005_bib0205","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1161\/01.ATV.18.10.1611","article-title":"The Gln-Arg 192 polymorphism of the human paraoxonase gene is not associated with coronary artery disease in Italian patients","volume":"18","author":"Herrmann","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.arteri.2016.07.005_bib0210","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.2337\/diabetes.49.8.1390","article-title":"Promoter polymorphism T(-107)C of the paraoxonase PON1 gene is a risk factor for coronary heart disease in type 2 diabetic patients","volume":"49","author":"James","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.arteri.2016.07.005_bib0215","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0021-9150(99)00311-1","article-title":"Common paraoxonasa gene variants, mortality risk and fatal cardiovascular events in elderly subjects","volume":"149","author":"Heijmans","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.arteri.2016.07.005_bib0220","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0140-6736(04)15642-0","article-title":"Four paraoxonase gene polymorphisms in 11,212 cases of coronary heart disease and 12,786 controls: metaanalysis of 43 studies","volume":"363","author":"Wheeler","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.arteri.2016.07.005_bib0225","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1161\/hq0901.094247","article-title":"Paraoxonase status in coronary heart disease: are activity and concentration more important than genotype","volume":"21","author":"Mackness","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.arteri.2016.07.005_bib0230","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1161\/01.CIR.101.19.2252","article-title":"Smoking is associated with reduced serum paraoxonase activity and concentration in coronary artery disease patients","volume":"101","author":"James","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.arteri.2016.07.005_bib0235","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0021-9150(99)00243-9","article-title":"Daily moderate alcohol consumption increases serum paraoxonase activity; a dietcontrolled, randomised intervention study in middle-aged men","volume":"147","author":"van der Gaag","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.arteri.2016.07.005_bib0240","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/00008571-199912000-00009","article-title":"Determination of paraoxonase (PON1) status requires more than genotyping","volume":"9","author":"Richter","year":"1999","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.arteri.2016.07.005_bib0245","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1016\/j.jacc.2006.01.074","article-title":"Association of paraoxonase-1 activity and concentration with angiographic severity and extent of coronary artery disease","volume":"47","author":"Gran\u00e9r","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.arteri.2016.07.005_bib0250","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s00726-012-1321-z","article-title":"Paraoxonase 1 and homocysteine metabolism","volume":"43","author":"Per\u0142a-Kaj\u00e1n","year":"2012","journal-title":"Amino Acids"},{"key":"10.1016\/j.arteri.2016.07.005_bib0255","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.atherosclerosis.2015.06.004","article-title":"Paraoxonase-1 and oxidized lipoprotein lipids. The Cardiovascular Risk in Young Finns Study","volume":"241","author":"Kresanov","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.arteri.2016.07.005_bib0260","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0891-5849(98)00272-X","article-title":"Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants","volume":"26","author":"Aviram","year":"1999","journal-title":"Free Radic Biol Med"},{"issue":"Pt 2","key":"10.1016\/j.arteri.2016.07.005_bib0265","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1042\/bj3040549","article-title":"Quantification of human serum paraoxonase by enzyme-linked immunoassay: population differences in protein concentrations","volume":"304","author":"Blatter Garin","year":"1994","journal-title":"Biochem J"},{"key":"10.1016\/j.arteri.2016.07.005_bib0270","doi-asserted-by":"crossref","first-page":"376","DOI":"10.5551\/jat.11320","article-title":"Serum PON-1 activity but not Q192R polymorphism is related to the extent of atherosclerosis","volume":"19","author":"Bayrak","year":"2012","journal-title":"J Atheroscler Thromb"}],"container-title":["Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0214916816301024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0214916816301024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T18:23:11Z","timestamp":1536258191000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0214916816301024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0214916816301024"],"URL":"https:\/\/doi.org\/10.1016\/j.arteri.2016.07.005","relation":{},"ISSN":["0214-9168"],"issn-type":[{"value":"0214-9168","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paraoxonase 1 (Q192R) gene polymorphism, coronary heart disease and the risk of a new acute coronary event","name":"articletitle","label":"Article Title"},{"value":"Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arteri.2016.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Sociedad Espa\u00f1ola de Arteriosclerosis. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}